Dr. Maxime Kinet, MD

Dr. Kinet practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kinet's NPI, 1518499763, was assigned on March 28, 2017. Dr. Kinet graduated from Weill Cornell Medicine in 2016. Dr. Kinet holds California license A159747.

Dr. Kinet's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kinet's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kinet to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kinet practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Kinet's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kinet is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kinet is licensed in California.

Dmand AI lists arteritis, arthritis, gout, joint pain and rheumatoid arthritis among the conditions Dr. Kinet treats.

CMS data shows 85 Medicare services from Dr. Kinet across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $5,021 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Kinet in 2024. The largest group is under 65, with 22 patients. 71% of them have high blood pressure, and 63% have arthritis. 49% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kinet's median patient age at 59, with 69% women.

In 2024, Dr. Kinet wrote 279 Medicare Part D claims for 29 patients. 43% of them were for generic drugs. CMS names the drug for 215 of them, across 8 drugs with 11 or more claims each, at $1,069,620 in total drug cost. In 2023, CMS named 158 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kinet for performance year 2024, reported as part of a group. Dr. Kinet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kinet as offering telehealth.

Dmand AI links 9 papers to Dr. Kinet, published from 2009 to 2023. 2016 was the busiest year, with 2. The most frequent topics are Caenorhabditis elegans and Caenorhabditis elegans Proteins. Dr. Kinet's most frequent co-authors are Elyse S. Blum, MD, Yun-Beom Choi, MD and Hobart W. Harris, MD.

CMS Open Payments shows 2 general payments to Dr. Kinet from 1 drug or device company from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $48.

Dr. Kinet graduated from Weill Cornell Medicine in 2016.

Dr. Kinet is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.